APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Capecitabine Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Capecitabine Tablets Industry Growth and Trends Forecast to 2032

Report ID 173974660127 December 2025105 pages

Choose your research edition.

Industry ResearchCapecitabine Tablets Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Capecitabine Tablets Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Capecitabine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Capecitabine Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Capecitabine Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Capecitabine Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Capecitabine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Capecitabine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Capecitabine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Capecitabine Tablets include Chia Tai-Tianqing Pharmaceutical, Chengdu Easton Biopharmaceuticals, Shanghai Sine Pharmaceutical, Shandong New Time Pharmaceutical, Qilu Pharmaceutical, Roche, Teva Pharmaceutical, Sun Pharma and Eugia Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Capecitabine Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Capecitabine Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Capecitabine Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Capecitabine Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Capecitabine Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Capecitabine Tablets Market by Company

Chia Tai-Tianqing Pharmaceutical

Chengdu Easton Biopharmaceuticals

Shanghai Sine Pharmaceutical

Shandong New Time Pharmaceutical

Qilu Pharmaceutical

Roche

Teva Pharmaceutical

Sun Pharma

Eugia Pharma

Dr. Reddy's Laboratories

Accord Healthcare

Capecitabine Tablets Segment by Type

150mg

500mg

Capecitabine Tablets Segment by Application

Colon Cancer

Breast Cancer

Stomach Cancer

Capecitabine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Capecitabine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Capecitabine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Capecitabine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Capecitabine Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Capecitabine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 150mg Table 2. Major Company of 500mg Table 3. Global Capecitabine Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Capecitabine Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Capecitabine Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Capecitabine Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Capecitabine Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Capecitabine Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Capecitabine Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Capecitabine Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Capecitabine Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Capecitabine Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Capecitabine Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Capecitabine Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Capecitabine Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Capecitabine Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Capecitabine Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Capecitabine Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Capecitabine Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Capecitabine Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Capecitabine Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Capecitabine Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Capecitabine Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Capecitabine Tablets Industry Trends Table 25. Capecitabine Tablets Industry Drivers Table 26. Capecitabine Tablets Industry Opportunities and Challenges Table 27. Capecitabine Tablets Industry Restraints Table 28. Global Capecitabine Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Capecitabine Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Capecitabine Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Capecitabine Tablets Sales Share by Company (2021-2026) Table 32. Global Capecitabine Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Capecitabine Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Capecitabine Tablets Major Company Production Sites and Headquarters Table 35. Global Capecitabine Tablets Company, Product Type & Application Table 36. Global Capecitabine Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Capecitabine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Capecitabine Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Capecitabine Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Capecitabine Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Capecitabine Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Capecitabine Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Capecitabine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Capecitabine Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Capecitabine Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Capecitabine Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Capecitabine Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Capecitabine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Capecitabine Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Capecitabine Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Capecitabine Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Capecitabine Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Capecitabine Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Capecitabine Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Capecitabine Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Capecitabine Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Capecitabine Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Capecitabine Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Capecitabine Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Capecitabine Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Capecitabine Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Capecitabine Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Capecitabine Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Capecitabine Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Capecitabine Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Capecitabine Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Capecitabine Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Capecitabine Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Capecitabine Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Chia Tai-Tianqing Pharmaceutical Company Information Table 72. Chia Tai-Tianqing Pharmaceutical Business Overview Table 73. Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product Portfolio Table 75. Chia Tai-Tianqing Pharmaceutical Recent Development Table 76. Chengdu Easton Biopharmaceuticals Company Information Table 77. Chengdu Easton Biopharmaceuticals Business Overview Table 78. Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product Portfolio Table 80. Chengdu Easton Biopharmaceuticals Recent Development Table 81. Shanghai Sine Pharmaceutical Company Information Table 82. Shanghai Sine Pharmaceutical Business Overview Table 83. Shanghai Sine Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Shanghai Sine Pharmaceutical Capecitabine Tablets Product Portfolio Table 85. Shanghai Sine Pharmaceutical Recent Development Table 86. Shandong New Time Pharmaceutical Company Information Table 87. Shandong New Time Pharmaceutical Business Overview Table 88. Shandong New Time Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shandong New Time Pharmaceutical Capecitabine Tablets Product Portfolio Table 90. Shandong New Time Pharmaceutical Recent Development Table 91. Qilu Pharmaceutical Company Information Table 92. Qilu Pharmaceutical Business Overview Table 93. Qilu Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Qilu Pharmaceutical Capecitabine Tablets Product Portfolio Table 95. Qilu Pharmaceutical Recent Development Table 96. Roche Company Information Table 97. Roche Business Overview Table 98. Roche Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Roche Capecitabine Tablets Product Portfolio Table 100. Roche Recent Development Table 101. Teva Pharmaceutical Company Information Table 102. Teva Pharmaceutical Business Overview Table 103. Teva Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Teva Pharmaceutical Capecitabine Tablets Product Portfolio Table 105. Teva Pharmaceutical Recent Development Table 106. Sun Pharma Company Information Table 107. Sun Pharma Business Overview Table 108. Sun Pharma Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sun Pharma Capecitabine Tablets Product Portfolio Table 110. Sun Pharma Recent Development Table 111. Eugia Pharma Company Information Table 112. Eugia Pharma Business Overview Table 113. Eugia Pharma Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Eugia Pharma Capecitabine Tablets Product Portfolio Table 115. Eugia Pharma Recent Development Table 116. Dr. Reddy's Laboratories Company Information Table 117. Dr. Reddy's Laboratories Business Overview Table 118. Dr. Reddy's Laboratories Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Dr. Reddy's Laboratories Capecitabine Tablets Product Portfolio Table 120. Dr. Reddy's Laboratories Recent Development Table 121. Accord Healthcare Company Information Table 122. Accord Healthcare Business Overview Table 123. Accord Healthcare Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Accord Healthcare Capecitabine Tablets Product Portfolio Table 125. Accord Healthcare Recent Development Table 126. North America Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 128. North America Capecitabine Tablets Sales Market Share by Country (2021-2026) Table 129. North America Capecitabine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Capecitabine Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. North America Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Capecitabine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Capecitabine Tablets Market Share by Country (2021-2026) Table 134. North America Capecitabine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Capecitabine Tablets Market Share Forecast by Country (2027-2032) Table 136. Europe Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 138. Europe Capecitabine Tablets Sales Market Share by Country (2021-2026) Table 139. Europe Capecitabine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Capecitabine Tablets Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Capecitabine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Capecitabine Tablets Market Share by Country (2021-2026) Table 144. Europe Capecitabine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Capecitabine Tablets Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Capecitabine Tablets Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Capecitabine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Capecitabine Tablets Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Capecitabine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Capecitabine Tablets Market Share by Country (2021-2026) Table 154. Asia-Pacific Capecitabine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Capecitabine Tablets Market Share Forecast by Country (2027-2032) Table 156. Latin America Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 158. Latin America Capecitabine Tablets Sales Market Share by Country (2021-2026) Table 159. Latin America Capecitabine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Capecitabine Tablets Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Capecitabine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Capecitabine Tablets Market Share by Country (2021-2026) Table 164. Latin America Capecitabine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Capecitabine Tablets Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Capecitabine Tablets Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Capecitabine Tablets Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Capecitabine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Capecitabine Tablets Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Capecitabine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Capecitabine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Capecitabine Tablets Market Share by Country (2021-2026) Table 174. Middle East and Africa Capecitabine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Capecitabine Tablets Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Capecitabine Tablets Distributors List Table 179. Capecitabine Tablets Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Capecitabine Tablets Image Figure 2. Global Capecitabine Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Capecitabine Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Capecitabine Tablets Sales (2021-2032) & (K Units) Figure 5. 150mg Image Figure 6. Global 150mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 500mg Image Figure 8. Global 500mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Capecitabine Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Capecitabine Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Capecitabine Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Capecitabine Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Capecitabine Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Capecitabine Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Capecitabine Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Capecitabine Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Capecitabine Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Capecitabine Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Capecitabine Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Capecitabine Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Capecitabine Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Colon Cancer Image Figure 24. Global Colon Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Breast Cancer Image Figure 26. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Stomach Cancer Image Figure 28. Global Stomach Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Capecitabine Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Capecitabine Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Capecitabine Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Capecitabine Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Capecitabine Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Capecitabine Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Capecitabine Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Capecitabine Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Capecitabine Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Capecitabine Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Capecitabine Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Capecitabine Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Capecitabine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Capecitabine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Capecitabine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Capecitabine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Capecitabine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Capecitabine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Capecitabine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Capecitabine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Capecitabine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Capecitabine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Capecitabine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Capecitabine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Capecitabine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Capecitabine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Capecitabine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Capecitabine Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Capecitabine Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg
  • 500mg
Applications
  • Colon Cancer
  • Breast Cancer
  • Stomach Cancer
Companies covered
  • Chia Tai-Tianqing Pharmaceutical
  • Chengdu Easton Biopharmaceuticals
  • Shanghai Sine Pharmaceutical
  • Shandong New Time Pharmaceutical
  • Qilu Pharmaceutical
  • Roche
  • Teva Pharmaceutical
  • Sun Pharma
  • Eugia Pharma
  • Dr. Reddy's Laboratories
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Capecitabine Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Capecitabine Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Capecitabine Tablets Market by Type
  6. 1.3.1 150mg
  7. 1.3.2 500mg
  8. 1.4 Global Capecitabine Tablets Market Size by Type
  9. 1.4.1 Global Capecitabine Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Capecitabine Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Capecitabine Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Capecitabine Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Capecitabine Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Capecitabine Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Capecitabine Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Capecitabine Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Capecitabine Tablets Industry Trends
  2. 2.2 Capecitabine Tablets Industry Drivers
  3. 2.3 Capecitabine Tablets Industry Opportunities and Challenges
  4. 2.4 Capecitabine Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Capecitabine Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Capecitabine Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Capecitabine Tablets Price (2021-2026)
  4. 3.4 Global Capecitabine Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Capecitabine Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Capecitabine Tablets Company, Product Type & Application
  7. 3.7 Global Capecitabine Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Capecitabine Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Capecitabine Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Capecitabine Tablets Tier 1, Tier 2, and Tier 3
4 Capecitabine Tablets Regional Status and Outlook
  1. 4.1 Global Capecitabine Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Capecitabine Tablets Historic Market Size by Region
  3. 4.2.1 Global Capecitabine Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Capecitabine Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Capecitabine Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Capecitabine Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Capecitabine Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Capecitabine Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Capecitabine Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Capecitabine Tablets by Application
  1. 5.1 Capecitabine Tablets Market by Application
  2. 5.1.1 Colon Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Stomach Cancer
  5. 5.2 Global Capecitabine Tablets Market Size by Application
  6. 5.2.1 Global Capecitabine Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Capecitabine Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Capecitabine Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Capecitabine Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Capecitabine Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Capecitabine Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Capecitabine Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Capecitabine Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chia Tai-Tianqing Pharmaceutical
  2. 6.1.1 Chia Tai-Tianqing Pharmaceutical Company Information
  3. 6.1.2 Chia Tai-Tianqing Pharmaceutical Business Overview
  4. 6.1.3 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product Portfolio
  6. 6.1.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
  7. 6.2 Chengdu Easton Biopharmaceuticals
  8. 6.2.1 Chengdu Easton Biopharmaceuticals Company Information
  9. 6.2.2 Chengdu Easton Biopharmaceuticals Business Overview
  10. 6.2.3 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product Portfolio
  12. 6.2.5 Chengdu Easton Biopharmaceuticals Recent Developments
  13. 6.3 Shanghai Sine Pharmaceutical
  14. 6.3.1 Shanghai Sine Pharmaceutical Company Information
  15. 6.3.2 Shanghai Sine Pharmaceutical Business Overview
  16. 6.3.3 Shanghai Sine Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Sine Pharmaceutical Capecitabine Tablets Product Portfolio
  18. 6.3.5 Shanghai Sine Pharmaceutical Recent Developments
  19. 6.4 Shandong New Time Pharmaceutical
  20. 6.4.1 Shandong New Time Pharmaceutical Company Information
  21. 6.4.2 Shandong New Time Pharmaceutical Business Overview
  22. 6.4.3 Shandong New Time Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shandong New Time Pharmaceutical Capecitabine Tablets Product Portfolio
  24. 6.4.5 Shandong New Time Pharmaceutical Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Capecitabine Tablets Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Capecitabine Tablets Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Teva Pharmaceutical
  38. 6.7.1 Teva Pharmaceutical Company Information
  39. 6.7.2 Teva Pharmaceutical Business Overview
  40. 6.7.3 Teva Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Capecitabine Tablets Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Recent Developments
  43. 6.8 Sun Pharma
  44. 6.8.1 Sun Pharma Company Information
  45. 6.8.2 Sun Pharma Business Overview
  46. 6.8.3 Sun Pharma Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharma Capecitabine Tablets Product Portfolio
  48. 6.8.5 Sun Pharma Recent Developments
  49. 6.9 Eugia Pharma
  50. 6.9.1 Eugia Pharma Company Information
  51. 6.9.2 Eugia Pharma Business Overview
  52. 6.9.3 Eugia Pharma Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Eugia Pharma Capecitabine Tablets Product Portfolio
  54. 6.9.5 Eugia Pharma Recent Developments
  55. 6.10 Dr. Reddy's Laboratories
  56. 6.10.1 Dr. Reddy's Laboratories Company Information
  57. 6.10.2 Dr. Reddy's Laboratories Business Overview
  58. 6.10.3 Dr. Reddy's Laboratories Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dr. Reddy's Laboratories Capecitabine Tablets Product Portfolio
  60. 6.10.5 Dr. Reddy's Laboratories Recent Developments
  61. 6.11 Accord Healthcare
  62. 6.11.1 Accord Healthcare Company Information
  63. 6.11.2 Accord Healthcare Business Overview
  64. 6.11.3 Accord Healthcare Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Accord Healthcare Capecitabine Tablets Product Portfolio
  66. 6.11.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Capecitabine Tablets Sales by Country
  2. 7.1.1 North America Capecitabine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Capecitabine Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Capecitabine Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Capecitabine Tablets Market Size by Country
  6. 7.2.1 North America Capecitabine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Capecitabine Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Capecitabine Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Capecitabine Tablets Sales by Country
  2. 8.1.1 Europe Capecitabine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Capecitabine Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Capecitabine Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Capecitabine Tablets Market Size by Country
  6. 8.2.1 Europe Capecitabine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Capecitabine Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Capecitabine Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Capecitabine Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Capecitabine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Capecitabine Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Capecitabine Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Capecitabine Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Capecitabine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Capecitabine Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Capecitabine Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Capecitabine Tablets Sales by Country
  2. 10.1.1 South America Capecitabine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Capecitabine Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Capecitabine Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Capecitabine Tablets Market Size by Country
  6. 10.2.1 South America Capecitabine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Capecitabine Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Capecitabine Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Capecitabine Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Capecitabine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Capecitabine Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Capecitabine Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Capecitabine Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Capecitabine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Capecitabine Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Capecitabine Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Capecitabine Tablets Value Chain Analysis
  2. 12.1.1 Capecitabine Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Capecitabine Tablets Production Mode & Process
  7. 12.2 Capecitabine Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Capecitabine Tablets Distributors
  10. 12.2.3 Capecitabine Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst